Antihypertensive efficacy and tolerability of candesartan–hydrochlorothiazide 32/12.5 mg and 32/25 mg in patients not optimally controlled with candesartan monotherapy

Autor: Bönner, Gerd, Balparda, C., Cuneo, C., Rojas, C., Jure, H., Luquez, H., Montaña, O., Salomone, O., Rodenas, P., Aizenberg, D., Lecocq, L., Saint-Lannes, M., Guerin, P., Jourde, P., Frohn, M., Richter, D., Leyendecker, P., Cantin, T., Smila, D., Aim, L., Combet, G., Bertrand, G., Lalanne, G., Dammann, H. -G., Radermacher, E., Strotmann, H. -J., Muenter, K. C., Daut, W., Chevts, J., Krause, G., Andreas, K., Hanefeld, M., Naumburger, A., Maus, O., Fiesselmann, A., Cama, R., Karnad, D., Thomas, M., Vidyasagar, S., Pedrinelli, R., Perticone, M., Mezzetti, A., Bosi, S., Di Biase, M., Mayer, M., Volpe, M., Uguccioni, M., Di Somma, S., Santonastaso, M., Rossi, P., Glorioso, N., Destro, M., Mos, L., Licata, G., Donadon, V., Locatelli, F., Vinciguerra, A., Sechi, L., Aucello, G., Gazzaruso, C., Bryce, A., Bustamante, G., Cabrera, W., Espinoza, J., Heredia, J., Horna, M., Parra, J., Toce, L., Watanabe, L., Kostenko, V., Butko, D., Svistov, A., Shoustov, S., Ershova, O., Konrady, A., Churina, S., Yspenskiy, Y., Petrov, A., Espinel-Garuz, E., Pau, J., Fluixa, C., Calabuig, J., Sipan, Y., Comino, L., Puig, J., Mengual, L., Perez, J., Vinyoles, E.

Publikováno v: Blood Pressure. 17:22-30

To evaluate the efficacy and tolerability of candesartan cilexetil 32 mg in combination with hydrochlorothiazide (HCT) 12.5 mg or 25 mg in hypertensive patients not optimally controlled with candesartan monotherapy.A total of 3521 patients with treat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::693058745ceea6997e45de70d8512d83
https://doi.org/10.1080/08038020802519220